Beta (β)-thalassemia is a blood disorder with an incidence of 1 in 100,000.1 This case report outlines a patient with β-thalassemia requiring cardiopulmonary bypass (CPB) and the measures taken to ensure an uneventful procedure.
OrigaR.β-Thalassemia. Genetics in Medicine2017; 19: 609–619.
3.
DesoukyOSSelimNSEl-BakrawyEMEl-MarakbySM.Biophysical characterization of beta-thalassemic red blood cells. Cell Biochem Biophys2009; 55: 45–53.
4.
El-BeshlawyARagabLFattahAAet al. Improvement of cardiac function in thalassemia major treated with L-carnitine. Acta Haematologica2004; 111: 143–148.
5.
FinchCADeubelbeissKCookJDet al. Ferrokinetics in man. Medicine1970; 49: 17–53.
6.
TheinSL.Genetic modifiers of beta-thalassemia. Haematologica2005; 90: 649–660.
7.
NaikSKKnightAElliottMJ.A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion1991; 6: 41–50.
8.
CokkinouVKatsiyanniAOrkopoulouMMichalisATolisGCokkinosDV.Evidence of increased hemolysis after open heart surgery in patients heterozygous for Beta-thalassemia. Tex Heart Inst J1988; 15: 35–38.
9.
SchaerDJBuehlerPWAlayashAIBelcherJDVercellottiGM.Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood2013; 121: 1276–1284.
10.
HansbroSDSharpeDACatchpoleRet al. Haemolysis during cardiopulmonary bypass: an in vivo comparison of standard roller pumps, non-occlusive roller pumps and centrifugal pumps. Perfusion1999; 14: 3–10.
